Latest News about SRPT
Recent news which mentions SRPT
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
September 03, 2024
From Benzinga
From Benzinga
2 Biotech Stocks to Buy Hand Over Fist in August
August 12, 2024
From Motley Fool
Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
From Benzinga
McKesson Reports Weak Sales, Joins JFrog, Fastly, Warner Bros. Discovery And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
August 08, 2024
From Benzinga
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
From InvestorPlace
Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript
August 08, 2024
Tickers
SRPT
From Motley Fool
Tickers
SRPT
From InvestorPlace
3 Genomics Stocks That May Transform Personalized Medicine
August 06, 2024
From InvestorPlace
Here's How Much $1000 Invested In Sarepta Therapeutics 10 Years Ago Would Be Worth Today
July 18, 2024
From Benzinga
From InvestorPlace
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
July 17, 2024
From Benzinga
Here's How Much $100 Invested In Sarepta Therapeutics 10 Years Ago Would Be Worth Today
July 04, 2024
From Benzinga
Tickers
SRPT
From Motley Fool
From Motley Fool
Here's How Much You Would Have Made Owning Sarepta Therapeutics Stock In The Last 10 Years
June 24, 2024
From Benzinga
From Benzinga
From Benzinga
Growth Stocks Leave Value Stocks In The Dust: 4 Reasons For Biggest Monthly Lead In Over A Year
June 21, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.